Short-course preoperative radiotherapy increases pelvic fracture risk in rectal cancer

被引:1
|
作者
Vesa, Valiaho [1 ,2 ]
Jaana, Makitalo [1 ,2 ,3 ]
Ia, Kohonen [4 ,5 ]
Anu, Carpelan [2 ,6 ]
Heikki, Minn [1 ,2 ]
Raija, Ristamaki [1 ,2 ]
Annika, Algars [1 ,2 ]
Eetu, Heerva [1 ,2 ]
机构
[1] Turku Univ Hosp, Dept Oncol, Hameentie 11, Turku 20521, Finland
[2] Univ Turku, Kiinamyllynkatu 4-8, Turku 20521, Finland
[3] Turku Univ Hosp, Dept Med Phys, Hameentie 11, Turku 20521, Finland
[4] Univ Turku, Med Res Lab, Tykistokatu 6A, Turku 20520, Finland
[5] Turku Univ Hosp, Med Imaging Ctr Southwest Finland, Hameentie 11, Turku 20521, Finland
[6] Turku Univ Hosp, Dept Digest Surg, Kiinamyllynkatu 4-8, Turku 20521, Finland
关键词
Rectal cancer; Neoadjuvant; Radiotherapy; Chemoradiotherapy; Fracture; TOTAL MESORECTAL EXCISION; RANDOMIZED PHASE-III; RADIATION-THERAPY; INSUFFICIENCY FRACTURES; FOLLOW-UP; CHEMORADIOTHERAPY; CHEMORADIATION; CARCINOMA; TRIAL;
D O I
10.1016/j.ctro.2023.100656
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Pelvic insufficiency fractures (PIFs) are adverse events associated with chemoradiotherapy (CRT) administered preoperatively in rectal cancer, with incidences of 0-33.6% reported in the literature. Data on PIFs after 5 x 5 Gy fractionated short-course radiotherapy (SCRT) using highly conformal radiotherapy techniques such as volumetric modulated arc therapy (VMAT) is limited.Methods: The Turku University Hospital colorectal cancer database was searched for patients operated on for stage I-III rectal cancer during the years 2014-2018. The hospital's routine follow-up includes a 2-year computed tomography (CT) scan, which was systemically re-evaluated to detect PIFs. Only radiotherapy delivered using VMAT and image-guided approaches was included. Baseline demographics, tumor data, and dose-volume data were collected to identify risk factors for PIFs.Results: Median time to CT scan was 24 months. Among the 164 patients analyzed, the 2-year PIF incidence was 22.2% for SCRT (n = 12/54, OR 9.1 (CI95% 1.9-42.9), p = 0.004), 9.1% for CRT (n = 4/44, OR 3.2 (CI95% 0.6-18.3), p = 0.13) and 3.0% (n = 2/66, reference) for those operated on without radiotherapy. The PIF incidence was not explained by differences in dose-volume data in either the SCRT or CRT groups. Fracture risk was higher in women, up to 50% after SCRT. Conclusions: Every fifth patient treated with SCRT and rectal surgery presented with a PIF. Critical bony structures to be avoided during radiotherapy contouring could not be identified. Clinicians, especially those involved with the follow-up of rectal cancer, should be aware of this potentially debilitating and surprisingly common adverse event.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Short-course preoperative radiotherapy combined with chemotherapy, delayed surgery and local hyperthermia for rectal cancer: a phase II study
    Rasulov, A. O.
    Gordeyev, S. S.
    Barsukov, Yu. A.
    Tkachev, S. I.
    Malikhov, A. G.
    Balyasnikova, S. S.
    Fedyanin, M. Yu.
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2017, 33 (04) : 465 - 470
  • [42] Clinical results and toxicity for short-course preoperative radiotherapy and total mesorectal excision in rectal cancer patients
    Sterzing, Florian
    Hoehle, Frieder
    Ulrich, Alexis
    Jensen, Alexandra
    Debus, Juergen
    Muenter, Marc
    JOURNAL OF RADIATION RESEARCH, 2015, 56 (01) : 169 - 176
  • [43] Preoperative short-course radiotherapy followed by consolidation chemotherapy for treatment with locally advanced rectal cancer: a meta-analysis
    Wu, Haoyan
    Fan, Chuanwen
    Fang, Chao
    Huang, Libin
    Li, Yuan
    Zhou, Zongguang
    RADIATION ONCOLOGY, 2022, 17 (01)
  • [44] Short-term outcome after neoadjuvant high-dose-rate endorectal brachytherapy or short-course external beam radiotherapy in resectable rectal cancer
    Hesselager, C.
    Vuong, T.
    Pahlman, L.
    Richard, C.
    Liberman, S.
    Letellier, F.
    Folkesson, J.
    COLORECTAL DISEASE, 2013, 15 (06) : 662 - 666
  • [45] A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS
    Gollins, Simon
    West, Nicholas
    Sebag-Montefiore, David
    Susnerwala, Shabbir
    Falk, Stephen
    Brown, Nick
    Saunders, Mark
    Quirke, Philip
    Ray, Ruby
    Parsons, Philip
    Griffiths, Gareth
    Maughan, Tim
    Adams, Richard
    Hurt, Chris
    BRITISH JOURNAL OF CANCER, 2018, 119 (06) : 697 - 706
  • [46] Is short-course radiotherapy and total neoadjuvant therapy the new standard of care in locally advanced rectal cancer? A sensitivity analysis of the RAPIDO clinical trial
    Jimenez-Fonseca, P.
    Salazar, R.
    Valenti, V.
    Msaouel, P.
    Carmona-Bayonas, A.
    ANNALS OF ONCOLOGY, 2022, 33 (08) : 786 - 793
  • [47] Pelvic insufficiency fractures frequently occur following preoperative chemo-radiotherapy for rectal cancer - a nationwide MRI study
    Jorgensen, J. B.
    Bondeven, P.
    Iversen, L. H.
    Laurberg, S.
    Pedersen, B. G.
    COLORECTAL DISEASE, 2018, 20 (10) : 873 - 880
  • [48] The safety of an MRI simulation-guided boost after short-course preoperative radiotherapy for unresectable rectal cancer (SUNRISE): interim analysis of a randomized phase II trial
    Liu, Wen-Yang
    Shi, Jin-Ming
    Li, Ning
    Wang, Xin
    Gao, Yuan-Hong
    Chi, Yihebali
    Sun, Yong-Kun
    Zhao, Qing
    Zhu, Yong-Jian
    Chen, Hong-Da
    Fang, Hui
    Lu, Ning-Ning
    Qi, Shu-Nan
    Chen, Bo
    Wang, Shu-Lian
    Song, Yong-Wen
    Liu, Yue-Ping
    Li, Ye-Xiong
    Liu, Zheng
    Zhou, Hai-Tao
    Liang, Jian-Wei
    Wang, Xi-Shan
    Zhang, Hai-Zeng
    Tang, Yuan
    Jin, Jing
    RADIATION ONCOLOGY, 2022, 17 (01)
  • [49] Potential dosimetric benefit of an adaptive plan selection strategy for short-course radiotherapy in rectal cancer patients
    Lutkenhaus, Lotte J.
    de Jong, Rianne
    Geijsen, Elisabeth D.
    Visser, Jorrit
    van Wieringen, Niek
    Bel, Arjan
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 (03) : 525 - 530
  • [50] Impact of the interval between short-course radiotherapy and surgery on outcomes of rectal cancer patients
    van den Broek, Colette B. M.
    Vermeer, Thomas A.
    Bastiaannet, Esther
    Rutten, Harm J. T.
    van de Velde, Cornelis J. H.
    Marijnen, Corrie A. M.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (15) : 3131 - 3139